Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
17.16
-0.23 (-1.32%)
Jun 5, 2025, 2:45 PM CST

SHE:002755 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Market Capitalization
16,14111,79710,0437,37011,81512,122
Upgrade
Market Cap Growth
71.05%17.47%36.27%-37.63%-2.53%-19.18%
Upgrade
Enterprise Value
13,9949,9558,4335,75710,47710,821
Upgrade
Last Close Price
17.3912.7110.827.9412.6012.73
Upgrade
PE Ratio
86.0773.60--31.1016.80
Upgrade
PS Ratio
8.786.646.963.943.803.21
Upgrade
PB Ratio
5.003.753.342.453.664.00
Upgrade
P/TBV Ratio
6.134.053.592.573.794.12
Upgrade
P/FCF Ratio
82.1765.20--27.2331.84
Upgrade
P/OCF Ratio
40.2128.68--20.8120.89
Upgrade
EV/Sales Ratio
7.615.605.843.083.372.86
Upgrade
EV/EBITDA Ratio
73.0558.61--26.1113.11
Upgrade
EV/EBIT Ratio
121.95105.29--33.8314.77
Upgrade
EV/FCF Ratio
71.2455.02--24.1428.42
Upgrade
Debt / Equity Ratio
0.020.020.040.020.000.01
Upgrade
Debt / EBITDA Ratio
0.290.42--0.030.02
Upgrade
Debt / FCF Ratio
0.280.40--0.030.05
Upgrade
Asset Turnover
0.460.470.420.530.831.01
Upgrade
Inventory Turnover
1.901.831.801.731.781.58
Upgrade
Quick Ratio
2.732.854.626.055.693.57
Upgrade
Current Ratio
2.953.135.076.606.193.84
Upgrade
Return on Equity (ROE)
4.89%4.18%-6.89%-8.53%12.16%26.14%
Upgrade
Return on Assets (ROA)
1.81%1.56%-5.23%-5.48%5.14%12.21%
Upgrade
Return on Capital (ROIC)
2.24%1.86%-5.85%-6.20%6.15%16.44%
Upgrade
Return on Capital Employed (ROCE)
3.50%2.90%--9.30%23.50%
Upgrade
Earnings Yield
1.14%1.36%-1.48%-3.06%3.21%5.95%
Upgrade
FCF Yield
1.22%1.53%-1.55%-2.76%3.67%3.14%
Upgrade
Dividend Yield
0.69%0.94%--0.79%1.57%
Upgrade
Payout Ratio
0.51%0.72%--48.89%28.43%
Upgrade
Buyback Yield / Dilution
4.03%-1.57%1.34%-1.55%-0.16%0.49%
Upgrade
Total Shareholder Return
4.73%-0.63%1.34%-1.55%0.64%2.06%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.